Literature DB >> 19025953

Evaluating the severity of nonalcoholic steatohepatitis with superparamagnetic iron oxide-enhanced magnetic resonance imaging.

Kengo Tomita1, Akihiro Tanimoto, Rie Irie, Masahiro Kikuchi, Hirokazu Yokoyama, Toshiaki Teratani, Takahiro Suzuki, Takashi Taguchi, Masaaki Noguchi, Tamiko Ohkura, Toshifumi Hibi.   

Abstract

PURPOSE: To evaluate the utility of noninvasive assessment of human nonalcoholic fatty liver disease (NAFLD) patients using superparamagnetic iron oxide (SPIO)-enhanced MRI.
MATERIALS AND METHODS: Nineteen NAFLD patients underwent SPIO-enhanced MRI. The values of tau, a time constant for an exponential approximation, were calculated using gradient-echo echo-planar imaging, and the values of %T2, a marker of the T2 relaxation effect of SPIO, were calculated using T2-weighted fast spin-echo images. Correlations between these values and the histological NAFLD activity scores were evaluated. The study protocol was approved by our Institutional Review Board and all patients gave informed consent.
RESULTS: There was a statistically significant relationship between the NAFLD activity scores and the tau values (r = 0.66, P = 0.002). The %T2 values were also significantly correlated with the NAFLD activity score (r = -0.58, P = 0.009). A cutoff tau value of 42.8 predicted "definitive NASH" (NAFLD activity score >or=5) with a specificity of 66.7% and a sensitivity of 99.9%, whereas a cutoff %T2 value of 32.5 predicted "definitive NASH" with a specificity of 72.7% and a sensitivity of 87.5%.
CONCLUSION: Noninvasive SPIO-enhanced MRI may be helpful for identifying NASH patients among patients suspected of having NAFLD. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19025953     DOI: 10.1002/jmri.21596

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

1.  A method for assessing metabolic information on liver and bone marrow by use of double gradient-echo with spectral fat suppression.

Authors:  Harumasa Kasai; Tosiaki Miyati; Tatsuya Kawai; Hirohito Kan; Makoto Kawano; Yuta Shibamoto
Journal:  Radiol Phys Technol       Date:  2014-01-10

2.  Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.

Authors:  Benjamin Pulli; Gregory Wojtkiewicz; Yoshiko Iwamoto; Muhammad Ali; Matthias W Zeller; Lionel Bure; Cuihua Wang; Yuri Choi; Ricard Masia; Alex R Guimaraes; Kathleen E Corey; John W Chen
Journal:  Radiology       Date:  2017-03-30       Impact factor: 11.105

3.  Evaluation of the uptake function of liver in rats with obstructive jaundice before and after relief from obstruction by superparamagnetic iron oxide-enhanced magnetic resonance imaging.

Authors:  Zhou Yiming; Jiang Lei; Zhai Renyou; Ke Shan; Li Xue; Liu Min; Gao Jun
Journal:  Oncol Lett       Date:  2012-05-24       Impact factor: 2.967

4.  Delayed hepatic signal recovery on ferucarbotran-enhanced magnetic resonance images: an experimental study in rat livers with gadolinium chloride-induced Kupffer cell damage.

Authors:  Toshihiro Furuta; Masayuki Yamaguchi; Ryutaro Nakagami; Masaaki Akahane; Manabu Minami; Kuni Ohtomo; Noriyuki Moriyama; Hirofumi Fujii
Journal:  MAGMA       Date:  2012-11-02       Impact factor: 2.310

5.  MR imaging in liver cirrhosis: classical and new approaches.

Authors:  Luis Martí-Bonmatí; Fructuoso Delgado
Journal:  Insights Imaging       Date:  2010-08-05

6.  Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.

Authors:  Harald Unterweger; Christina Janko; Marc Schwarz; László Dézsi; Rudolf Urbanics; Jasmin Matuszak; Erik Őrfi; Tamás Fülöp; Tobias Bäuerle; János Szebeni; Clément Journé; Aldo R Boccaccini; Christoph Alexiou; Stefan Lyer; Iwona Cicha
Journal:  Int J Nanomedicine       Date:  2017-07-24

7.  Accuracy of proton magnetic resonance for diagnosing non-alcoholic steatohepatitis: a meta-analysis.

Authors:  Tae-Hoon Kim; Chang-Won Jeong; Hong Young Jun; ChungSub Lee; SiHyeong Noh; Ji Eon Kim; SeungJin Kim; Kwon-Ha Yoon
Journal:  Sci Rep       Date:  2019-10-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.